Clinical advances in the development of novel VEGFR2 inhibitors

Por Fontanella, Caterina, Ongaro, Elena, Bolzonello, Silvia, Guardascione, Michela, Fasola, Gianpiero, Aprile, Giuseppe
Publicado no Ann Transl Med (2014)

Evidence-based appraisal of the upfront treatment for unresectable metastatic colorectal cancer patients

Por Aprile, Giuseppe, Lutrino, Stefania Eufemia, Ferrari, Laura, Casagrande, Mariaelena, Bonotto, Marta, Ongaro, Elena, Puglisi, Fabio
Publicado em 2013

Timing and extent of response in colorectal cancer: critical review of current data and implication for future trials

Por Aprile, Giuseppe, Fontanella, Caterina, Bonotto, Marta, Rihawi, Karim, Lutrino, Stefania Eufemia, Ferrari, Laura, Casagrande, Mariaelena, Ongaro, Elena, Berretta, Massimiliano, Avallone, Antonio, Rosati, Gerardo, Giuliani, Francesco, Fasola, Gianpiero
Publicado no Oncotarget (2015)

HER-2 inhibition in gastric and colorectal cancers: tangible achievements, novel acquisitions and future perspectives

Por Fanotto, Valentina, Ongaro, Elena, Rihawi, Karim, Avallone, Antonio, Silvestris, Nicola, Fornaro, Lorenzo, Vasile, Enrico, Antonuzzo, Lorenzo, Leone, Francesco, Rosati, Gerardo, Giuliani, Francesco, Bordonaro, Roberto, Scartozzi, Mario, Maglio, Giovanna De, Negri, Francesca V., Fasola, Gianpiero, Aprile, Giuseppe
Publicado no Oncotarget (2016)

Prognostic significance of K-Ras mutation rate in metastatic colorectal cancer patients

Por Vincenzi, Bruno, Cremolini, Chiara, Sartore-Bianchi, Andrea, Russo, Antonio, Mannavola, Francesco, Perrone, Giuseppe, Pantano, Francesco, Loupakis, Fotios, Rossini, Daniele, Ongaro, Elena, Bonazzina, Erica, Dell'Aquila, Emanuela, Imperatori, Marco, Zoccoli, Alice, Bronte, Giuseppe, De Maglio, Giovanna, Fontanini, Gabriella, Natoli, Clara, Falcone, Alfredo, Santini, Daniele, Onetti-Muda, Andrea, Siena, Salvatore, Tonini, Giuseppe, Aprile, Giuseppe
Publicado no Oncotarget (2015)